Lipitor and Pegasys drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Lipitor (atorvastatin calcium) and Pegasys (peginterferon alfa 2a). Common drug interactions include blood bilirubin increased among females and fatigue among males.
The phase IV clinical study analyzes what interactions people have when they take Lipitor and Pegasys. It is created by eHealthMe based on reports of 129 people who take the same drugs from the FDA, and is updated regularly.
What is Lipitor?
Lipitor has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 259,048 Lipitor users. Check the latest studies of Lipitor.
What is Pegasys?
Pegasys has active ingredients of peginterferon alfa 2a. It is often used in hepatitis c. eHealthMe is studying from 57,446 Pegasys users. Check the latest studies of Pegasys.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
129 people who take Lipitor and Pegasys together, and have interactions are studied.
What are the common drug interactions of Lipitor and Pegasys, by gender? *
What are the common drug interactions of Lipitor and Pegasys, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Lipitor and Pegasys?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Lipitor and Pegasys:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lipitor:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Pegasys:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lipitor and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Pegasys and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Proti? D, Balti? S, Stupar N, Pavlov-Dolijanovi? S, Mugo?a S, Todorovi? Z, "A case of myositis with immunological background associated with statin use", Open Medicine, 2014 Oct .
- Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .
- Proti? D, Balti? S, Stupar N, Pavlov-Dolijanovi? S, Mugo?a S, Todorovi? Z, "A case of myositis with immunological background associated with statin use", Open Medicine, 2014 Oct .
- Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on atorvastatin calcium and peginterferon alfa 2a (the active ingredients of Lipitor and Pegasys, respectively), and Lipitor and Pegasys (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Morphine Sulfate and Red Blood Cell Count Decreased for Men aged 40-49 - now
- Could Cabazitaxel cause Fatigue? - 2 seconds ago
- Gastroesophageal Reflux Disease and Irritable Bowel Syndrome Aggravated - 2 seconds ago
- Could Spironolactone cause Heart Disease Aggravated? - 3 seconds ago
- Could Piperacillin And Tazobactam cause Transient Ischaemic Attack? - 6 seconds ago
- Drug interactions of Glyburide and Wellbutrin - 7 seconds ago
- Vesicare and Gastroesophageal Reflux Disease for Women aged 50-59 - 10 seconds ago
- Vesicare and Gastro-Oesophageal Reflux Disease for Women aged 50-59 - 10 seconds ago
- Vesicare and Reflux for Women aged 50-59 - 10 seconds ago
- Vesicare and Heartburn for Women aged 50-59 - 10 seconds ago